Type IA variation for application CDSCO-2022-0013. Type IA variation: Manufacturing Process Change for Upadacitimab — major revision

Variation Number
CDSCO-2022-0013-V413
Type
Type IA
Application
Status
Overdue
Fee
€2,657
Submitted
2023-08-02
Approved
—
Description

Type IA variation: Manufacturing Process Change for Upadacitimab — major revision